Peroxynitrite, an oxidant generated by the interaction between superoxide and nitric oxide (NO), has been implicated in the etiology of numerous disease processes. Several studies have shown that peroxynitriteinduced protein nitration may compromise enzyme and protein function. We hypothesized that peroxynitrite may regulate cytokine function during inflammation. To test this hypothesis, the eosinophil chemotactic responses of eotaxin incubated with and without peroxynitrite were evaluated. Peroxynitrite attenuated eotaxin-induced eosinophil chemotactic activity (ECA) in a dose-dependent manner ( P Ͻ 0.05). The inhibitory effects were not significant on ECA induced by leukotriene B 4 or complement-activated serum incubated with peroxynitrite. The reducing agents deferoxamine and dithiothreitol reversed the ECA inhibition by peroxynitrite, and exogenous L -tyrosine abrogated the inhibition by peroxynitrite. PAPA-NONOate (an NO donor) or a combination of xanthine and xanthine oxidase to generate superoxide did not show an inhibitory effect on ECA induced by eotaxin. In contrast, 3-morpholinosydnonimine, a peroxynitrite generator, caused a concentration-dependent inhibition of ECA by eotaxin. Consistent with its capacity to reduce ECA, peroxynitrite treatment reduced eotaxin binding to eosinophils. Nitrotyrosine was detected in the eotaxin incubated with peroxynitrite. These findings are consistent with nitration of tyrosine by peroxynitrite with subsequent inhibition of eotaxin binding to eosinophils and a reduction in ECA. These data demonstrate that peroxynitrite modulates the eosinophil migration by eotaxin, and suggest that oxidants may play an important role in regulation of eotaxin-induced eosinophil chemotaxis. 
Peroxynitrite, an oxidant generated by the interaction between superoxide and nitric oxide (NO), has been implicated in the etiology of numerous disease processes. Several studies have shown that peroxynitriteinduced protein nitration may compromise enzyme and protein function. We hypothesized that peroxynitrite may regulate cytokine function during inflammation. To test this hypothesis, the eosinophil chemotactic responses of eotaxin incubated with and without peroxynitrite were evaluated. Peroxynitrite attenuated eotaxin-induced eosinophil chemotactic activity (ECA) in a dose-dependent manner ( P Ͻ 0.05). The inhibitory effects were not significant on ECA induced by leukotriene B 4 or complement-activated serum incubated with peroxynitrite. The reducing agents deferoxamine and dithiothreitol reversed the ECA inhibition by peroxynitrite, and exogenous L -tyrosine abrogated the inhibition by peroxynitrite. PAPA-NONOate (an NO donor) or a combination of xanthine and xanthine oxidase to generate superoxide did not show an inhibitory effect on ECA induced by eotaxin. In contrast, 3-morpholinosydnonimine, a peroxynitrite generator, caused a concentration-dependent inhibition of ECA by eotaxin. Consistent with its capacity to reduce ECA, peroxynitrite treatment reduced eotaxin binding to eosinophils. Nitrotyrosine was detected in the eotaxin incubated with peroxynitrite. These findings are consistent with nitration of tyrosine by peroxynitrite with subsequent inhibition of eotaxin binding to eosinophils and a reduction in ECA. These data demonstrate that peroxynitrite modulates the eosinophil migration by eotaxin, and suggest that oxidants may play an important role in regulation of eotaxin-induced eosinophil chemotaxis. Eotaxin is a recently characterized chemokine that has selective chemotactic activity for eosinophils. Eotaxin increases the chemotaxis of eosinophils, but not of neutrophils, monocytes, or lymphocytes, in vitro (1) (2) (3) (4) . In guinea pigs, eotaxin causes the accumulation of eosinophils within the lung, and Northern blot analysis demonstrates constitutive expression of eotaxin messenger RNA (mRNA) in the airways that increases considerably after allergen challenge (2, 3) . It has been suggested that eotaxin contributes to the pathogenesis of asthma by the specific recruitment of eosinophils into the airways (5) .
Increased production of nitric oxide (NO) and superoxide, components of peroxynitrite, have been implicated in the pathogenesis of asthma (6, 7) . Levels of NO are elevated in the air exhaled by persons with asthma (8) , and may contribute to airway edema and mucus hypersecretion (6) . High levels of superoxide anion have also been found in bronchoalveolar lavage fluid (BALF) of asthmatic patients (9) . Moreover, superoxide dismutase activity is reduced in the leukocytes of asthmatic patients (10) , and increased formation of peroxynitrite in the airways of asthmatic patients has been reported (11) . In view of these findings, chemotactic factors, including eotaxin, are likely to encounter high local concentrations of NO, superoxide, and peroxynitrite in inflammatory sites.
In addition to its role in oxidative reactions, peroxynitrite also nitrates free or protein-associated tyrosine to form the stable product nitrotyrosine by addition of a nitro group to the 3-position adjacent to the hydroxyl group of tyrosine (12) . Several studies have shown that peroxynitrite-induced protein nitration may compromise protein function (13) . We hypothesized that peroxynitrite might regulate eosinophil recruitment by modulating eotaxin. To test this hypothesis, the chemotactic responses of human eosinophils to eotaxin incubated with peroxynitrite and other compounds were evaluated in vitro. We found that peroxynitrite and 3-morpholinosydnonimine (SIN-1), a donor of peroxynitrite, significantly attenuated eotaxin-induced eosinophil chemotactic activity (ECA). In contrast, activated serum and leukotriene B 4 (LTB 4 )-induced ECA was not inhibited by peroxynitrite significantly. These data suggest that peroxynitrite plays an important role in regulating ECA during inflammation.
Materials and Methods

Measurement of ECA
Eosinophils were isolated with a modified method of Hansel and colleagues (14) with a magnetic cell-separation system. Briefly, venous blood anticoagulated with 130 mM trisodium citrate was obtained from normal human volunteers and diluted with phosphate-buffered saline (PBS) in a 1:1 ratio. Diluted blood was overlayered on an isotonic Percoll solution (density 1.082 g/ml; Sigma, St. Louis, MO), then centrifuged at 1,000 ϫ g for 30 min at 4 Њ C with a Beckman TJ-6 centrifuge. The supernatant and mononuclear cells at the interface were carefully removed, and red blood cells in the sediment were lysed with two cycles of hypotonic lysis (0.1% KHCO 3 and 0.83% NH 4 Cl). Isolated granulocytes were washed twice with [1,4-piperazine-bis (ethane sulfonic acid)] (Pipes) buffer (25 mM Pipes, 50 mM NaCl, 5 mM KCl, 25 mM NaOH, and 5.4 mM glucose, pH 7.4) containing 1% defined calf serum (DCS) (Hyclone Laboratories, Logan, UT), and an approximately equal volume of anti-CD16 antibody conjugated with magnetic particles (Miltenyi Biotec, Bergisch Gladbach, Germany) was added to the cell pellet. After a 60-min incubation on ice, 5 ml of Pipes buffer with 1% DCS were added to the cell-antibody mixture. The resuspended cells were loaded onto the separation column positioned in the magnetic cell separation system with a strong magnetic field. The cells were eluted three times with 5 ml of Pipes buffer with 1% DCS. Purity of the eosinophils counted by Randolph's stain was Ͼ 94%. Viability was Ͼ 98%, assessed by eosin or trypan blue exclusion. The eosinophils were resuspended in Gey's solution at 2.0 ϫ 10 6 cells/ml and used for the chemotaxis assay.
ECA was assayed in 48-well microchemotaxis chambers (Neuroprobe, Inc., Cabin John, MD) as previously described (15) . The bottom wells of the chamber were filled with 25 l of the chemotactic stimulus or media in duplicate. A 10-m-thick polyvinylpyrrolidone-free polycarbonate filter with a pore size of 5 m was placed over the samples. The silicon gasket and the upper pieces of the chamber were applied and 50 l of the cell suspension was placed into the upper wells. The chambers were incubated in humidified air in 5% CO 2 at 37 Њ C for 90 min. Nonmigrated cells were wiped away from the filter. The filter was immersed in methanol for 5 min, stained with a modified Wright's stain, and mounted on a glass slide. Cells that had completely migrated through the filter were counted using light microscopy. ECA was expressed as the mean number of migrated cells per high-power field from duplicate wells.
Effects of Peroxynitrite on Eotaxin-Induced ECA
Peroxynitrite was evaluated for its capacity to modulate eotaxin-induced ECA in vitro. Eotaxin (R&D Systems, Minneapolis, MN) was incubated for 2 h at 37 Њ C with each concentration of peroxynitrite (Calbiochem, La Jolla, CA) before the ECA assay. In control experiments, eotaxin was incubated with medium alone. 4 and Activated, Serum-Induced ECA The capacity of peroxynitrite to modulate LTB 4 and activated, serum-induced ECA was evaluated to compare with eotaxin. LTB 4 (1 m; Sigma) or complement-activated serum (16) (1:10 dilution) was incubated with peroxynitrite (100 M) for 2 h at 37 Њ C before performing the ECA assay.
Effects of Peroxynitrite on LTB
Effects of PAPA-NONOate on Eotaxin-Induced ECA
To evaluate the ability of NO to modulate eotaxin-induced ECA, we utilized PAPA-NONOate (Alexis Corp., San Diego, CA) as a NO donor (17) . Eotaxin (100 ng/ml) was incubated with PAPA-NONOate (10 Ϫ 6 , 10 Ϫ 5 , 10 Ϫ 4 , and 10 Ϫ 3 M) for 2 h at 37 Њ C before performing the ECA assay.
Effects of Xanthine/Xanthine Oxidase on Eotaxin-Induced ECA
To evaluate the effect of superoxide on eotaxin-induced ECA, xanthine (10 Ϫ 6 , 10 Ϫ 5 , 10 Ϫ 4 , and 10 Ϫ 3 M; Sigma) and xanthine oxidase (3.4 ϫ 10 Ϫ 6 , 3.4 ϫ 10 Ϫ 5 , 3.4 ϫ 10 Ϫ 4 , and 3.4 ϫ 10 Ϫ 3 U/ml; Sigma) were combined to produce superoxide (18) . Eotaxin (100 ng/ml) was incubated with xanthine and xanthine oxidase for 2 h at 37 Њ C before performing the ECA assay.
Effects of SIN-1 on Eotaxin-Induced ECA
The capacity of SIN-1 (Alexis Corp.), a peroxynitrite generator (19) , to modulate eotaxin-induced ECA was evaluated by incubating eotaxin (100 ng/ml) with SIN-1 (10 Ϫ 4 , 10 Ϫ 5 , 10 Ϫ 6 , and 10 Ϫ 7 M) for 2 h at 37 Њ C before performing the ECA assay.
Effects of Reducing Agents on Peroxynitrite-Induced Attenuation of ECA by Eotaxin
The capacity of the reducing agents dithiothreitol (DTT) or deferoxamine (DEF) to attenuate the effect of peroxynitrite on eotaxin-induced ECA by peroxynitrite was assessed. DTT (10 Ϫ 3 M; Sigma), DEF (5 ϫ 10 Ϫ 5 M; Sigma) and peroxynitrite (10 Ϫ 4 M) were added to eotaxin (100 ng/ ml) and incubated for 2 h at 37 Њ C before evaluation for ECA.
Effects of L -Tyrosine on Peroxynitrite-Induced Attenuation of ECA by Eotaxin
The capacity of L -tyrosine to reserve the attenuation of ECA induced by peroxynitrite was assessed by addition of L -tyrosine (10
, and 10 Ϫ 4 M; Sigma) to eotaxin (100 ng/ml) before exposure to peroxynitrite (10 Ϫ 4 M).
Detection of Nitrotyrosine on Eotaxin Incubated with Peroxynitrite
Detection of nitrotyrosine on eotaxin incubated with peroxynitrite was evaluated using a modification of a previously described enzyme-linked immunosorbent assay (ELISA) (20) . Eotaxin (100 ng/ml) was incubated with peroxynitrite (10 Ϫ 4 M) as described earlier and frozen until assayed. A total of 200 l of eotaxin was added to flat-bottomed 96-well plates (Costar, Cambridge, MA) and allowed to adsorb to the plastic for 2 h at 4 Њ C. After washing the flatbottomed plate three times with PBS-Tween, 200 l of a 1:400 dilution of rabbit polyclonal antinitrotyrosine (Calbiochem) was added to the wells and incubated for 90 min. After again washing three times with PBS-Tween, 200 l of a 1:500 dilution of peroxidase-conjugated antirabbit immunoglobulin G was added to the wells and incubated for 90 min. A total of 200 l of o -penylenediamine (100 g/ml; Sigma) in 0.003% hydrogen peroxide was added and visually monitored. The reaction was terminated by addition of 25 l of 8 N H 2 SO 4 and the absorbance read at 490 nm.
Effects of Peroxynitrite on Eotaxin Binding to Eosinophils
To investigate the peroxynitrite effect on eotaxin binding to eosinophils, eotaxin was incubated with 100 m of peroxynitrite for 2 h at 37 Њ C. In control experiments, eotaxin was incubated with medium alone. Subsequently, eotaxin with or without peroxynitrite was incubated with eosinophils (10 6 cells) at 4 Њ C for 30 min. Supernatants were then removed and eosinophils were washed three times in Hanks' balanced salt solution. Eosinophils were suspended in 1 ml PBSTween, sonicated for 20 s (MSE Soniprep, Crawley, UK), and then centrifuged at 20,000 ϫ g for 30 min in a refrigerated microcentrifuge to obtain a supernatant (soluble) and particulate fraction. Eotaxin was then measured using a commercially available eotaxin ELISA (R&D Systems).
Statistics
In experiments, the differences between groups were tested using Student's paired t test. In all cases, a P value of Ͻ 0.05 was considered significant. Data in figures are expressed as means Ϯ standard error of the mean.
Results
Effects of Peroxynitrite on ECA by Eotaxin
Various amounts of eotaxin were incubated with peroxynitrite (10 Ϫ 4 M). At each concentration, exposure to peroxynitrite caused a reduction in ECA (Figure 1 ; n ϭ 6, P Ͻ 0.05). Incubation of eotaxin (100 ng/ml) with various amounts of peroxynitrite induced a significant, concentration-dependent attenuation of ECA (Figure 2 ; n ϭ 6, P Ͻ 0.05). The lowest dose of peroxynitrite that significantly inhibited ECA was 10 Ϫ5 M (P Ͻ 0.05). Peroxynitrite itself was not chemotactic for eosinophils and did not alter the pH of the eotaxin solution (data not shown). Incubation of peroxynitrite (10 Ϫ4 M) with the eosinophils before the chemotaxis assay did not inhibit ECA to eotaxin (data not shown). The stable end products of peroxynitrite, nitrite, and nitrate (10 Ϫ4 M) did not inhibit ECA. 4 and Activated, Serum-Induced ECA To ensure that the effect of peroxynitrite was not a nonspecific effect on eosinophil chemotaxis, the effect of peroxynitrite on ECA induced by LTB 4 and complementactivated serum was assessed. Peroxynitrite did not significantly inhibit the ECA of LTB 4 or complement-activated serum ( Figure 3 ; n ϭ 4, P Ͻ 0.05).
Effects of Peroxynitrite on LTB
Effects of PAPA-NONOate on Eotaxin-Induced ECA
To evaluate the capacity of NO to modulate eotaxin-induced ECA, the effect of the NO donor PAPA-NONOate was evaluated. PAPA-NONOate did not significantly change ECA induced by eotaxin (data not shown, P Ͼ 0.05, all comparisons). A total of 100 ng/ml of eotaxin was cultured for 2 h in the presence of medium alone or peroxynitrite at the concentrations indicated; n ϭ 6 each condition. ECA is on the ordinate and the concentration of peroxynitrite is on the abscissa. *P Ͻ 0.05 compared with eotaxin incubated with medium alone.
Effects of Xanthine/Xanthine Oxidase on Eotaxin-Induced ECA
We investigated the effect of superoxide on ECA induced by eotaxin and eotaxin incubated with xanthine and xanthine oxidase. Xanthine and xanthine oxidase did not change ECA by eotaxin (data not shown, P Ͼ 0.05, all comparisons).
Effects of SIN-1 on Eotaxin-Induced ECA SIN-1, a nitrovasodilator, spontaneously decomposes under aqueous conditions, generating first O 2Ϫ and then NO at comparable rates, forming peroxynitrite (21) . SIN-1 induced a significant, concentration-dependent attenuation of ECA by eotaxin (Figure 4 ; n ϭ 6, P Ͻ 0.05). The lowest dose of SIN-1 to inhibit ECA was 10 Ϫ5 M (P Ͻ 0.05). The quantity of 100 M of SIN-1 at a concentration of 10 Ϫ4 M induced 85% attenuation of ECA by eotaxin. SIN-1 itself was not chemotactic for eosinophils (data not shown).
Effects of Reducing Agents on Peroxynitrite-Induced Attenuation of ECA by Eotaxin
The reducing agents DTT and DEF were added to eotaxin before incubating with peroxynitrite. Each attenuated the inhibition of ECA induced by peroxynitrite ( Figure 5 ; n ϭ 4, P Ͻ 0.05). Neither DTT nor DEF alone was chemotactic for eosinophils (data not shown).
Effects of L-Tyrosine on Peroxynitrite-Induced Attenuation of ECA by Eotaxin
One mechanism of peroxynitrite inhibition may be through nitrating tyrosine residues. Therefore, the effect of addition of L-tyrosine to eotaxin before incubating with per- Figure 3 . Effect of peroxynitrite on ECA induced by eotaxin, activated serum, and LTB 4 . Eotaxin, activated serum, and LTB 4 were cultured for 2 h in the presence of medium alone or 10 Ϫ4 M peroxynitrite; n ϭ 4 each condition. ECA is on the ordinate and the experimental groups are on the abscissa. *P Ͻ 0.05 compared with eotaxin incubated with medium alone. 
Detection of Nitrotyrosine on Eotaxin Incubated with Peroxynitrite
The optical density of eotaxin with peroxynitrite incubation was significantly higher than that of eotaxin without peroxynitrite incubation. Peroxynitrite resulted in nitrotyrosine formation on eotaxin (Figure 7 ; n ϭ 6, P Ͻ 0.05). Peroxynitrite (10 Ϫ4 M) incubated with Voller's buffer for 2 h did not affect binding in the ELISA.
Effects of Peroxynitrite on Eotaxin Binding to Eosinophils
Eotaxin induces chemotactic activity by binding to eosinophils. Addition of peroxynitrite to eotaxin resulted in an inhibition of eotaxin binding to eosinophils (Figure 8 ; n ϭ 4, P Ͻ 0.05). Peroxynitrite had no significant effect on the eotaxin ELISA at the same concentration (data not shown).
Discussion
The results of this study show that the peroxynitrite significantly attenuated eotaxin-induced ECA in vitro. The inhibitory effects of peroxynitrite were not significant on ECA induced by LTB 4 and activated serum. DEF, DTT, or L-tyrosine attenuated the inhibition. NO or superoxide did not cause the reduction in ECA because neither PAPA-NONOate nor xanthine/xanthine oxidase showed an inhibitory effect. Addition of peroxynitrite to eotaxin resulted in an inhibition of eotaxin binding to eosinophils. The peroxynitrite donor SIN-1 induced a significant, concentration-dependent inhibition of ECA by eotaxin. These data suggest that peroxynitrite plays an important role in regulating human eosinophil locomotion by eotaxin.
Eotaxin is a recently characterized chemokine that has selective chemotactic activity for eosinophils. Atopic asthmatic patients have high concentrations of eotaxin in BALF and an increased expression of eotaxin mRNA in the epithelium and submucosa of the airways (5) . Challenge of the airways of sensitized guinea pigs with aerosolized ovalbumin resulted in eosinophil accumulation and increase of eotaxin in the airway tissue and BALF (22) . The above data suggest that eotaxin may contribute to the pathogenesis of asthma by the specific recruitment of eosinophils into the airways.
NO and superoxide are both formed by endothelial cells, neutrophils, and macrophages. Recent evidence suggests that under certain conditions, NO synthase can simultaneously generate both superoxide and NO (23) . When produced in proximity, superoxide and NO can react at an almost diffusion-limited rate to produce peroxynitrite (24) . Peroxynitrite is an oxidizing and nitrating agent that reacts with a variety of molecules, including lipids, proteins, and deoxyribonucleic acid (25) (26) (27) (28) . Peroxynitrite, or one of its intermediate reactive species, can react with phenolic compounds such as tyrosine to form nitrated (3-nitrotyrosine) products (29, 30) . Stable 3-nitrotyrosine products have been detected in tissues after asthma (11) and acute lung injury (31, 32) . Thom and associates (33) reported that nitrotyrosine concentration in lung homogenates of 30 to 60 ng/mg protein. If peroxynitrite concentrations were of the same order, the peroxynitrite concentration in this experiment should be sufficient to modulate eotaxin function.
Coincubation of eotaxin with several peroxynitrite scavengers ameliorated ECA inhibition. The protective effect of DTT on eotaxin may suggest the involvement of cysteine residues nitrosylation, however DTT also prevented peroxynitrite-mediated nitration of tyrosine (34) . The iron chelator DEF also inhibited peroxynitrite-induced inhibition of eotaxin ECA but is also scavenger of peroxynitrite reaction independent of iron chelation (35) . In addition, L-tyrosine abrogated the peroxynitrite ECA inhibition. These results are consistent with tyrosine nitration by peroxynitrite or its intermediates as a mechanism for eotaxin inhibition.
Some studies reported that NO donors or NO synthase inhibitors have produced variable effects on phagocyte Figure 7 . Detection of nitrotyrosine on eotaxin incubated with peroxynitrite. Eotaxin was incubated with 10 Ϫ4 M of peroxynitrite for 2 h; n ϭ 6 each condition. Optical density is on the ordinate and the experimental groups are on the abscissa. *P Ͻ 0.05 compared with eotaxin incubated without peroxynitrite. Figure 8 . Effect of peroxynitrite on eotaxin binding to eosinophils. Eotaxin was incubated with and without 10 Ϫ4 M of peroxynitrite for 2 h at 37ЊC; after that, eotaxin was incubated with eosinophils (10 Ϫ6 cells) at 37ЊC for 30 min. Eotaxin binding to eosinophils was measured by ELISA; n ϭ 4 each condition. Eotaxin concentration is on the ordinate and the experimental groups are on the abscissa. *P Ͻ 0.05 compared with eotaxin incubated with medium alone.
chemotaxis in vitro (36) (37) (38) (39) (40) . The effect of peroxynitrite on eosinophils is negligible in our assay because the half-time of peroxynitrite is so short that eosinophils would not have a peroxynitrite effect after the 2-h incubation time. We also incubated eosinophils with peroxynitrite for 90 min at 37ЊC before the chemotaxis experiments and induced no significant cytotoxicity on eosinophils as assessed by trypan blue exclusion. Lastly, peroxynitrite had no significant effect when incubated with the eosinophils on ECA to eotaxin.
Chemokines induce leukocyte migration by binding to specific G protein-coupled, seven transmembrane-spanning, cell-surface receptors. Although the mechanism of binding eotaxin to eosinophil receptors has not been understood, the N-terminal and loop regions of the C-C chemokines have been thought to be important for receptor binding and signaling. Tyrosine residues have been reported to be important in the binding of monocyte chemoattractant protein-1 (MCP-1), another C-C chemokine, to its receptor. Steitz and coworkers (41) reported that point mutations of Tyr-13 greatly lowered MCP-1 receptor binding and activity. Zhang and colleagues (42) reported that changing Tyr-28 to aspartate essentially abolished MCP-1's monocyte chemoattractant activity. Interestingly, the amino acid sequence of eotaxin from 48 through 54 is identical to 27 through 33 on MCP-1 and both sequences contain tyrosine residues (41, 43) . Our findings of nitrotyrosine formation on eotaxin after peroxynitrite incubation are consistent with these observations, and suggest that tyrosine nitration by peroxynitrite may be a mechanism that alters eotaxin binding and chemotactic function. However, peroxynitrite may potentially affect protein function by other mechanisms including methionine (44) , tryptophan (45) , or formation of s-nitroso-thiol groups on cysteines (46) .
The evidence for a role of peroxynitrite in vivo is based on detection of 3-nitrotyrosine in injured tissues, however an additional mechanism of tyrosine nitration independent of peroxynitrite has been demonstrated (47) . Nitrogen dioxide (NO 2 ) promotes tyrosine nitration through formation of nitryl chloride (Cl-NO 2 ) and NO 2 by reaction with the inflammatory mediators hypochlorous acid (HOCl) or myeloperoxidase. Peroxidases may potentially affect protein function by not only nitrating but also chlorinating or brominating tyrosine residues (48) . Therefore, it cannot be stated definitively that the formation of nitrotyrosine in vivo is due to peroxynitrite.
In summary, we found that peroxynitrite modulates ECA in vitro, and it is suggested that nitration of a tyrosine residue is responsible for inhibition of eotaxin-induced ECA. These data suggest that peroxynitrite attenuates eotaxin-induced chemotactic activity and plays an important role in regulating human eosinophil locomotion during inflammation.
